TTY Biopharm Company Limited (4105.TWO)
TWD 72.7
(-0.41%)
TWD 72.7
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.08 Billion | 1.23 Billion | 1.25 Billion | 526.35 Million | - |
| Net Income | 1.41 Billion | 1.4 Billion | 1.08 Billion | 1.2 Billion | - |
| Depreciation & Amortization | 200.89 Million | 186.27 Million | 167.28 Million | 156.99 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -359.74 Million | -46.43 Million | 263.44 Million | -380.95 Million | - |
| Other non-cash items | -26.69 Million | 670 Thousand | 20.83 Million | 11.16 Million | - |
| Investing Cash Flow | -2.63 Million | -133.13 Million | -168.77 Million | 147.23 Million | - |
| Investments in PPE | -99.58 Million | -135.5 Million | -74.15 Million | -181.86 Million | - |
| Acquisitions | 17 Million | - | - | - | -262.35 Million |
| Investment purchases | - | -10.5 Million | -34.8 Million | - | - |
| Sales/Maturities of investments | 168.55 Million | 45.17 Million | 20.7 Million | 308.82 Million | - |
| Other Investing Activities | -78.61 Million | -41.69 Million | -80.55 Million | 20.25 Million | - |
| Financing Cash Flow | -816.32 Million | -1.1 Billion | -1.04 Billion | -806.6 Million | - |
| Debt repayment | -51.55 Million | -324.67 Million | -20.54 Million | -210.35 Million | - |
| Dividends payments | -845.41 Million | -745.94 Million | -994.6 Million | -994.59 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -16.74 Million | -24.83 Million | -28.98 Million | -22.35 Million | - |
| Accounts receivables | -119.89 Million | - | - | - | - |
| Accounts payables | 11.94 Million | - | - | - | - |
| Inventory | -56.75 Million | -83.95 Million | 155.11 Million | -251.8 Million | - |
| Other working capital | -183.09 Million | - | - | - | - |
| Cash at beginning of period | 2.35 Billion | 2.22 Billion | 2.22 Billion | 2.42 Billion | - |
| Cash at end of period | 2.62 Billion | 2.35 Billion | 2.22 Billion | 2.22 Billion | - |
| Capital Expenditure | -99.58 Million | -135.5 Million | -74.15 Million | -181.86 Million | - |
| Effect of forex changes on cash | -2.65 Million | 135.84 Million | -44.91 Million | -65.4 Million | - |
| Net cash flow / Change in cash | 263.69 Million | 135.07 Million | -1.47 Million | -198.42 Million | - |
| Free Cash Flow | 985.73 Million | 1.1 Billion | 1.18 Billion | 344.49 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 349.51 Million | 368.05 Million | 227.04 Million | 1.41 Billion | 505.69 Million | 393.38 Million |
| Depreciation & Amortization | 44.23 Million | 49.05 Million | 49.17 Million | 200.89 Million | 47.11 Million | 54.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -121.63 Million | -45.14 Million | 236.42 Million | -359.74 Million | -427.62 Million | -92.4 Million |
| Other non-cash items | -16.14 Million | 3.25 Million | -5.63 Million | -26.69 Million | -10.6 Million | -8.11 Million |
| Investing Cash Flow | -148.42 Million | -104.95 Million | -65.64 Million | -2.63 Million | -30.89 Million | 98.81 Million |
| Investments in PPE | -22 Million | -23.58 Million | -28.78 Million | -99.58 Million | -30.67 Million | -29.17 Million |
| Acquisitions | -242.86 Million | - | - | - | - | - |
| Investment purchases | 85.9 Million | - | -158.82 Million | - | 158.82 Million | - |
| Sales/Maturities of investments | 100.21 Million | -85.9 Million | 159.43 Million | 168.55 Million | -157.76 Million | 173.26 Million |
| Other Investing Activities | 16.23 Million | 2.27 Million | -37.46 Million | -78.61 Million | -1.27 Million | -45.33 Million |
| Financing Cash Flow | -123.66 Million | -201.26 Million | -336 Million | -816.32 Million | -202.89 Million | -151.52 Million |
| Debt repayment | -750 Million | -200 Million | -344.35 Million | -51.55 Million | -174.72 Million | -695.3 Million |
| Dividends payments | -870.27 Million | - | -26.55 Million | -845.41 Million | -26.55 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 6000.00 | 188 Thousand | - | -16.74 Million | - | -1000.00 |
| Accounts receivables | -6.44 Million | - | - | - | - | - |
| Accounts payables | -96.59 Million | - | - | - | - | - |
| Inventory | -11.65 Million | 4.25 Million | 251.03 Million | -56.75 Million | -297.97 Million | -20.77 Million |
| Other working capital | -7.35 Million | - | - | - | - | - |
| Cash at beginning of period | 2.72 Billion | 2.62 Billion | 2.52 Billion | 2.35 Billion | 2.63 Billion | 2.44 Billion |
| Cash at end of period | 2.57 Billion | 2.72 Billion | 2.62 Billion | 2.62 Billion | 2.52 Billion | 2.63 Billion |
| Capital Expenditure | -22 Million | -23.58 Million | -28.78 Million | -99.58 Million | -30.67 Million | -29.17 Million |
| Effect of forex changes on cash | 20.16 Million | 64.47 Million | -73.87 Million | -2.65 Million | 57.01 Million | 23.53 Million |
| Net cash flow / Change in cash | -155.48 Million | 108.25 Million | 98.22 Million | 263.69 Million | -109.91 Million | 191.07 Million |
| Free Cash Flow | 74.44 Million | 326.41 Million | 544.95 Million | 985.73 Million | 36.17 Million | 191.08 Million |
ADT1
FLYE
AOA
HAYD
8341
5974